The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Statin use for primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD) in breast cancer (BC) patients (pts).
 
John W. Melson
No Relationships to Disclose
 
Benjamin Koethe
No Relationships to Disclose
 
Sharanya Mohanty
No Relationships to Disclose
 
Seda Babroudi
No Relationships to Disclose
 
Chen Bao
No Relationships to Disclose
 
Amar Chunduru
No Relationships to Disclose
 
Henry Dwaah
No Relationships to Disclose
 
Matthew Finn
No Relationships to Disclose
 
Annika Jain
No Relationships to Disclose
 
Mumtu Lalla
No Relationships to Disclose
 
Paras Patnaik
No Relationships to Disclose
 
Rachael Studley
No Relationships to Disclose
 
Rachel J. Buchsbaum
Patents, Royalties, Other Intellectual Property - “Potent Agelastatin Derivatives as Modulators for Cancer Invasion and Metastasis” Provisional patent application: Docket Number: MITX-9505/00US 317239-2690 5/13/2017 application in collaboration with Dr. Mohammad Movassaghi (Inst)
 
Kathryn Huber
No Relationships to Disclose
 
Susan K. Parsons
Consulting or Advisory Role - Seagen
 
Jenica N Upshaw
No Relationships to Disclose